Researchers at Cuba's National Medical Genetics Center: Pioneering Studies on COVID-19.

IF 1.8 4区 医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Medicc Review Pub Date : 2021-01-01 Epub Date: 2021-01-30 DOI:10.37757/MR2021.V23.N1.5
Gail A Reed
{"title":"Researchers at Cuba's National Medical Genetics Center: Pioneering Studies on COVID-19.","authors":"Gail A Reed","doi":"10.37757/MR2021.V23.N1.5","DOIUrl":null,"url":null,"abstract":"<p><p>Three fourths of the 175 staff at Cuba's National Medical Genetics Center (CNGM) are women. And women constitute 90% of the research team working on the Center's largest current project-unlocking the biological secrets of COVID-19 in the Cuban population. They are identifying particularly vulnerable groups and geographies, reviewing therapies applied and long-term sequelae of the disease, and contributing to ongoing vaccine research and trials. Their results are critical to determining effective preventive and treatment strategies as the country moves into the next phases of epidemic control. The national study is the first and only one of its kind in Latin America. Then the first COVID-19 cases were diagnosed in Cuba on March 11, 2020, the Center's role in epidemiological surveillance was activated, based on its experience with the Zika threat in 2015. This involved mobilizing the National Genetics Network anchored in primary healthcare facilities, comprised of 452 genetics counselors, nurses and clinical geneticists, supported by technicians, epidemiologists and family doctors. The Network's role would become key to the ensuing research. As the magnitude of the pandemic became clearer, CNGM investigators approached the Ministry of Public Health and government leaders with a broad-ranging proposal to study biological factors that would help explain differences in vulnerability, symptoms, immune response and severity of the disease, as well as its profile in different Cuban subpopulations. After approval, the studies got underway in June, encompassing Cubans who had been infected through June 11, 2020, and were by now convalescing. The nine main research lines were defined, and principal investigators went to work developing the instruments needed and training personnel across the island on their use. While final results are still being analyzed, CNGM Director Dr Beatriz Marcheco and four lead researchers talked with MEDICC Review about the scope of their work and some of the most intriguing preliminary findings.</p>","PeriodicalId":49835,"journal":{"name":"Medicc Review","volume":"23 1","pages":"12-17"},"PeriodicalIF":1.8000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicc Review","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.37757/MR2021.V23.N1.5","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/30 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Three fourths of the 175 staff at Cuba's National Medical Genetics Center (CNGM) are women. And women constitute 90% of the research team working on the Center's largest current project-unlocking the biological secrets of COVID-19 in the Cuban population. They are identifying particularly vulnerable groups and geographies, reviewing therapies applied and long-term sequelae of the disease, and contributing to ongoing vaccine research and trials. Their results are critical to determining effective preventive and treatment strategies as the country moves into the next phases of epidemic control. The national study is the first and only one of its kind in Latin America. Then the first COVID-19 cases were diagnosed in Cuba on March 11, 2020, the Center's role in epidemiological surveillance was activated, based on its experience with the Zika threat in 2015. This involved mobilizing the National Genetics Network anchored in primary healthcare facilities, comprised of 452 genetics counselors, nurses and clinical geneticists, supported by technicians, epidemiologists and family doctors. The Network's role would become key to the ensuing research. As the magnitude of the pandemic became clearer, CNGM investigators approached the Ministry of Public Health and government leaders with a broad-ranging proposal to study biological factors that would help explain differences in vulnerability, symptoms, immune response and severity of the disease, as well as its profile in different Cuban subpopulations. After approval, the studies got underway in June, encompassing Cubans who had been infected through June 11, 2020, and were by now convalescing. The nine main research lines were defined, and principal investigators went to work developing the instruments needed and training personnel across the island on their use. While final results are still being analyzed, CNGM Director Dr Beatriz Marcheco and four lead researchers talked with MEDICC Review about the scope of their work and some of the most intriguing preliminary findings.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
古巴国家医学遗传学中心的研究人员:对COVID-19的开创性研究。
古巴国家医学遗传学中心(CNGM)的175名工作人员中有四分之三是妇女。在该中心目前最大的项目——揭开古巴人口中COVID-19的生物学秘密——的研究团队中,女性占90%。他们正在确定特别脆弱的群体和地区,审查所采用的治疗方法和该疾病的长期后遗症,并为正在进行的疫苗研究和试验作出贡献。随着国家进入下一阶段的流行病控制,其结果对于确定有效的预防和治疗战略至关重要。这项全国性的研究是拉丁美洲第一次也是唯一的一次。2020年3月11日,古巴确诊了第一例COVID-19病例,根据2015年应对寨卡病毒威胁的经验,该中心在流行病学监测方面的作用被激活。这涉及动员设在初级保健设施的全国遗传学网络,由452名遗传学顾问、护士和临床遗传学家组成,并得到技术人员、流行病学家和家庭医生的支持。网络的作用将成为随后研究的关键。随着这一流行病的严重程度日益明朗,CNGM的调查人员与公共卫生部和政府领导人接触,提出了一项广泛的建议,研究有助于解释这种疾病在易感性、症状、免疫反应和严重程度方面的差异的生物因素,以及它在古巴不同亚群体中的特点。获得批准后,这些研究于6月开始进行,研究对象包括2020年6月11日之前被感染、目前正在康复的古巴人。确定了9条主要研究路线,主要研究人员着手开发所需的仪器,并对全岛的人员进行使用方面的培训。虽然最终结果仍在分析中,但CNGM主任Beatriz Marcheco博士和四位主要研究人员向《医学评论》(MEDICC Review)介绍了他们的工作范围和一些最有趣的初步发现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Medicc Review
Medicc Review PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-
CiteScore
3.30
自引率
9.50%
发文量
49
审稿时长
>12 weeks
期刊介绍: Uphold the highest standards of ethics and excellence, publishing open-access articles in English relevant to global health equity that offer the best of medical, population health and social sciences research and perspectives by Cuban and other developing-country professionals.
期刊最新文献
Executive Summary: Insights from Cuba's COVID-19 Vaccine Enterprise: Report from a High Level Fact-Finding Delegation to Cuba. COVID-19, Viruses and Dementia. Full Technical Report: Insights from Cuba's COVID-19 Vaccine Enterprise: Report from a High Level Fact-Finding Delegation to Cuba. Health Care is a Right, Not a Commodity: The Legacy of Dr Paul Farmer MD PhD. Validation of a New Diagnostic Index to Determine Metabolic Obesity Phenotypes in Normal-Weight Women in Early Pregnancy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1